SCHEMBL1390278

SCHEMBL1390278

Cc1ccccc1C(CC(=O)c1ccc(O)cc1)c1ccc(Br)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 3/20 0.52
GAA P10253 3/20 0.52
SI P14410 3/20 0.52
MGAM2 Q2M2H8 3/20 0.52
KMT2A Q03164 3/20 0.47
GPBAR1 Q8TDU6 3/20 0.47
DPP4 P27487 1/20 0.42
LMNA P02545 1/20 0.42
HSD17B10 Q99714 1/20 0.42
L3MBTL1 Q9Y468 3/20 0.41
POLB P06746 1/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
AHR P35869 1/20 0.40
MEN1 O00255 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1390205 0.86 L3MBTL1 (0.59) MGAMGAASIMGAM2KMT2A
SCHEMBL363384 0.86 MGAM (0.51) MGAMGAASIMGAM2KMT2A
SCHEMBL1390411 0.86 GAA (0.48) MGAMGAASIMGAM2KMT2A
SCHEMBL363583 0.84 GPBAR1 (0.59) MGAMGAASIMGAM2KMT2A
SCHEMBL1389925 0.84 GPBAR1 (0.59) MGAMGAASIMGAM2KMT2A
SCHEMBL1389922 0.84 GPBAR1 (0.59) MGAMGAASIMGAM2KMT2A
SCHEMBL1390101 0.82 MGAM (0.47) MGAMGAASIMGAM2KMT2A
SCHEMBL369941 0.82 KMT2A (0.49) MGAMGAASIMGAM2KMT2A
SCHEMBL1390346 0.82 GPBAR1 (0.56) MGAMGAASIMGAM2KMT2A
SCHEMBL370252 0.82 MGAM (0.53) MGAMGAASIMGAM2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 MGAM 2443/4885GAA 2696/4885SI 3902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.